Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (MAGI-1) is a multi-domain scaffolding protein that plays a pivotal role in the organization of protein complexes at cell-cell junctions (UniProt Q96QZ7). It is characterized by the presence of six PDZ domains, which serve as versatile modules for protein-protein interactions, particularly with the C-terminal motifs of various signaling and structural proteins (PubMed: 11836245). MAGI-1 is essential for the maintenance of tight junctions and the regulation of cell polarity, making it a key player in epithelial and endothelial integrity. In clinical contexts, MAGI-1 is a well-known target of high-risk human papillomavirus (HPV) E6 oncoproteins, which bind to its PDZ domains and trigger its proteasomal degradation, a process that contributes to viral-induced oncogenesis (PubMed: 10906120). Beyond viral infections, MAGI-1 acts as a tumor suppressor in several cancers, and its dysregulation is associated with inflammatory conditions and neurological disorders (PubMed: 25863144). Current therapeutic research explores the use of peptidomimetics and small molecules designed to competitively inhibit the binding of pathogenic ligands to MAGI-1 PDZ domains, thereby preserving its structural and signaling functions.
Inhibition of protein-protein interactions (PPI) by blocking the PDZ domain binding pockets to prevent pathogenic degradation or to stabilize signaling complexes.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (MAGI-1) (MAGI-1).